The reported statements, read against the company's own industry.
Financials view
Market Capitalization
2.26BCNY
339.00M · vs all stocks (USD)
Updated Oct 23, 2026
Revenue (TTM)
565.28MCNY
84.78M · vs all stocks (USD)
Updated Oct 23, 2026
Profit Margin
-18.85%
vs Medical Instruments & Supplies peers
Updated Oct 23, 2026
Beta
0.4290x
vs all stocks
Updated Oct 23, 2026
52-Week Change
20.31%
vs all stocks
Updated Oct 23, 2026
Market Capitalization
2.26BCNY
339.00M · vs all stocks (USD)
Updated Oct 23, 2026
Enterprise Value
2.70BCNY
404.55M · vs all stocks (USD)
Updated Oct 23, 2026
Price to Sales (TTM)
4.10x
vs Medical Instruments & Supplies peers
Provider-reported. Market Capitalization ÷ Revenue (TTM) on this page gives 4×.Updated Oct 23, 2026
Price to Book (MRQ)
14.56x
vs Medical Instruments & Supplies peers
Updated Oct 23, 2026
Enterprise to Revenue
4.77x
vs Medical Instruments & Supplies peers
Updated Oct 23, 2026
Enterprise to EBITDA
-75.14x
vs Medical Instruments & Supplies peers
Updated Oct 23, 2026
Gross Margin
12.04%
vs Medical Instruments & Supplies peers
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 2.08%.Updated Oct 23, 2026
Profit Margin
-18.85%
vs Medical Instruments & Supplies peers
Updated Oct 23, 2026
Operating Margin
-7.47%
vs Medical Instruments & Supplies peers
Updated Oct 23, 2026
Return on Assets (TTM)
-5.69%
vs Medical Instruments & Supplies peers
Updated Oct 23, 2026
Return on Equity (TTM)
-48.64%
vs Medical Instruments & Supplies peers
Updated Oct 23, 2026
Revenue (TTM)
565.28MCNY
84.78M · vs all stocks (USD)
Updated Oct 23, 2026
Revenue per Share (TTM)
1.92CNYUpdated Oct 23, 2026
Quarterly Revenue Growth
-14.40%
vs Medical Instruments & Supplies peers
Updated Oct 23, 2026
Gross Profit (TTM)
11.76MCNY
1.76M · vs all stocks (USD)
Updated Oct 23, 2026
EBITDA (TTM)
-35.90MCNY
-5.38M · vs all stocks (USD)
Updated Oct 23, 2026
Net Income (TTM)
-106.53MCNY
-15.98M · vs all stocks (USD)
Updated Oct 23, 2026
Quarterly Earnings Growth (YoY)
-32.28%
vs Medical Instruments & Supplies peers
Updated Oct 23, 2026
Operating Cash Flow (TTM)
16.11MCNY
2.42M · vs all stocks (USD)
Updated Oct 23, 2026
Levered Free Cash Flow (TTM)
34.99MCNY
5.25M · vs all stocks (USD)
Updated Oct 23, 2026
Payout Ratio
139.69%
vs Medical Instruments & Supplies peers
Updated Oct 23, 2026
Minority Interest (Equity)
3.98MCNYFY2025 · Dec 31, 2025
Revenue
600.51MCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
577.08MCNYFY2025 · Dec 31, 2025
Gross Profit
23.43MCNYFY2025 · Dec 31, 2025
Operating Income
-59.89MCNY
-8.98M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
-93.14MCNYFY2025 · Dec 31, 2025
Income Tax Expense
7.97MCNYFY2025 · Dec 31, 2025
Net Income
-101.12MCNYFY2025 · Dec 31, 2025
EBIT
-71.41MCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
-5.92MCNYFY2025 · Dec 31, 2025
Research & Development
28.61MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
19.37MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
7.09MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
62.70KCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
21.73MCNYFY2025 · Dec 31, 2025
EPS (Basic)
-0.3500CNYFY2025 · Dec 31, 2025
EPS (Diluted)
-0.3500CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
290.60MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
290.60MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
-101.12MCNYFY2025 · Dec 31, 2025
Minority Interests (P&L)
-594.67KCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
-34.96MCNYFY2025 · Dec 31, 2025
Free Cash Flow
-48.16MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
12.58MCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
-101.12MCNYFY2025 · Dec 31, 2025
Other Non-cash Items
25.01MCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
-7.63MCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
48.78MCNYFY2025 · Dec 31, 2025
Capital Expenditures
-13.20MCNYFY2025 · Dec 31, 2025
Net Acquisitions
-1.74MCNYFY2025 · Dec 31, 2025
Sale of Investments
9.03MCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
-5.91MCNYFY2025 · Dec 31, 2025
Long-term Debt Issuance
570.14MCNYFY2025 · Dec 31, 2025
Long-term Debt Payments
-610.83MCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-25.90MCNYFY2025 · Dec 31, 2025
Other Financing Charges
-432.00KCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
-67.02MCNYFY2025 · Dec 31, 2025
Shares Outstanding
289.04MSharesUpdated Oct 23, 2026
Float Shares
137.54MSharesUpdated Oct 23, 2026
% Held by Insiders
53.02%
vs all stocks
Updated Oct 23, 2026
% Held by Institutions
3.08%
vs all stocks
Updated Oct 23, 2026
Total Cash (MRQ)
57.95MCNY
8.69M · vs all stocks (USD)
Updated Oct 23, 2026
Total Cash per Share (MRQ)
0.2000CNYUpdated Oct 23, 2026
Total Debt (MRQ)
433.06MCNY
64.95M · vs all stocks (USD)
Updated Oct 23, 2026
Total Debt to Equity (MRQ)
2.65x
vs Medical Instruments & Supplies peers
Updated Oct 23, 2026
Current Ratio (MRQ)
0.4460x
vs Medical Instruments & Supplies peers
Updated Oct 23, 2026
Book Value per Share (MRQ)
0.5510CNYUpdated Oct 23, 2026
Total Assets
927.94MCNY
139.17M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
322.00MCNYFY2025 · Dec 31, 2025
Total Liabilities
746.77MCNYFY2025 · Dec 31, 2025
Total Non-current Assets
605.94MCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
83.39MCNYFY2025 · Dec 31, 2025
Total Current Liabilities
663.38MCNYFY2025 · Dec 31, 2025
Cash
12.58MCNYFY2025 · Dec 31, 2025
Cash Equivalents
13.27MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
25.86MCNYFY2025 · Dec 31, 2025
Other Short-term Investments
22.50MCNYFY2025 · Dec 31, 2025
Accounts Receivable
114.99MCNYFY2025 · Dec 31, 2025
Inventory
138.82MCNYFY2025 · Dec 31, 2025
Accounts Payable
245.80MCNYFY2025 · Dec 31, 2025
Short-term Debt
380.01MCNYFY2025 · Dec 31, 2025
Other Current Liabilities
11.02MCNYFY2025 · Dec 31, 2025
Long-term Debt
73.83MCNYFY2025 · Dec 31, 2025
Other Non-current Liabilities
568.44KCNYFY2025 · Dec 31, 2025
Common Stock (Book)
289.04MCNYFY2025 · Dec 31, 2025
Retained Earnings
-259.94MCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
181.17MCNY
27.17M · vs all stocks (USD)
FY2025 · Dec 31, 2025
52-Week Low
5.30CNYUpdated Oct 23, 2026
52-Week High
10.39CNYUpdated Oct 23, 2026
52-Week Change
20.31%
vs all stocks
Updated Oct 23, 2026
Beta
0.4290x
vs all stocks
Updated Oct 23, 2026
50-Day MA
8.97CNYUpdated Oct 23, 2026
200-Day MA
7.55CNYUpdated Oct 23, 2026
Avg 10-Day Volume
7.98MSharesUpdated Oct 23, 2026
Avg 30-Day Volume
9.34MSharesUpdated Oct 23, 2026
Diluted EPS (TTM)
-0.3700CNYUpdated Oct 23, 2026
2 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Debt is a large share of its assets, and large against its cash flow.
Reads
Elevated Leverage on Three Denominators
Debt sits high against its equity, its assets, and its cash flow.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Gross margin is 12%, lower than 95% of its Medical Instruments & Supplies peers (median 49.2%)Significant